3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
3
Breast Neoplasms
3
Stomach Neoplasms
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Transitional Cell
2
Adenocarcinoma Of Esophagus
2
Uterine Cervical Neoplasms
1
Salivary Gland Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasms
1
Head and Neck Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Biliary Tract Neoplasms
1
Advanced Malignancies
1
Interventions
fludarabine
2
durvalumab
2
Gemcitabine
2
Cyclophosphamide
2
Cisplatin
2
trastuzumab deruxtecan
1
tivozanib
1
guadecitabine
1
atezolizumab
1
Taxes
1
Specimen Handling
1
S 1 (combination)
1
Platinum
1
Oxaliplatin
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Leucovorin
1
Ipilimumab
1
Folfox protocol
1
Fluorouracil
1
Capecitabine
1
CTLA-4 Antigen
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gallbladder Neoplasms
×
zanidatamab
×
30 days
×
Clear all
No trials found.